Efficacy and safety of lacidipine and amlodipine on blood pressure in Korean ISH [isolated systolic hypertension] patients aged 60 to 80 years (ELDER).

Trial Profile

Efficacy and safety of lacidipine and amlodipine on blood pressure in Korean ISH [isolated systolic hypertension] patients aged 60 to 80 years (ELDER).

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Mar 2010

At a glance

  • Drugs Amlodipine; Lacidipine
  • Indications Isolated systolic hypertension
  • Focus Therapeutic Use
  • Acronyms ELDER
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 09 Mar 2010 Actual end date added to 1 Feb 2010 as reported by ClinicalTrials.gov.
    • 09 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top